Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 0.0.

  • Altimmune's Asset Utilization Ratio fell 6977.91% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 6977.91%. This contributed to the annual value of 0.0 for FY2024, which is 9439.8% down from last year.
  • Per Altimmune's latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2025, which was down 6977.91% from 0.0 recorded in Q2 2025.
  • Altimmune's Asset Utilization Ratio's 5-year high stood at 0.04 during Q1 2021, with a 5-year trough of 0.0 in Q3 2025.
  • Over the past 5 years, Altimmune's median Asset Utilization Ratio value was 0.0 (recorded in 2023), while the average stood at 0.01.
  • As far as peak fluctuations go, Altimmune's Asset Utilization Ratio tumbled by 9837.4% in 2022, and later surged by 66151.26% in 2024.
  • Over the past 5 years, Altimmune's Asset Utilization Ratio (Quarter) stood at 0.02 in 2021, then crashed by 98.37% to 0.0 in 2022, then skyrocketed by 617.8% to 0.0 in 2023, then tumbled by 93.83% to 0.0 in 2024, then dropped by 29.75% to 0.0 in 2025.
  • Its Asset Utilization Ratio stands at 0.0 for Q3 2025, versus 0.0 for Q2 2025 and 0.0 for Q1 2025.